Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT

Nonmyeloablative regimens are used for allogeneic hematopoietic cell transplantation (HCT) of older or medically unfit patients, but successful outcome is still hindered by graft-versus-host disease (GVHD), especially in the setting of HLA-mismatched HCT. New GVHD prophylaxis strategies are emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Velden, Walter J. F. M., Choi, Goda, de Witte, Moniek A., van der Meer, Arnold, de Haan, Anton F. J., Blijlevens, Nicole M. A., Huls, Gerwin, Kuball, Jürgen, van Dorp, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214052/
https://www.ncbi.nlm.nih.gov/pubmed/34148060
http://dx.doi.org/10.1038/s41409-021-01369-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214052/
https://www.ncbi.nlm.nih.gov/pubmed/34148060
http://dx.doi.org/10.1038/s41409-021-01369-9

Ejemplares similares